Issues related to pharmaceutical pricing. Issues related to drug shortages. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
Literal federal measure citations: H.R. 1
2025 · 3rd Quarter (July 1 - Sep 30)
BAXTER HEALTHCARE CORPORATION
Filed by BAXTER HEALTHCARE CORPORATION.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $360,000.00
- Registrant
- BAXTER HEALTHCARE CORPORATION
- Filing UUID
- ee9b7339-552a-47c8-9575-7799923ee3e8
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues relating to drug pricing, 340B Drug pricing, device sterilization. Issues relating to safe mobility and issues relating to diabetic retinopathy. Issues relating to pandemic preparedness act. Issues related to artificial intelligence technology in healthcare; issues related to Hurricane Helene. Issues around emergency preparedness and critical medical supplies.
Issues related to increasing funding for Strategic National Stockpile. Labor, Health, and Human Services appropriations.
Taxation of multinational companies. Monitor tax reform proposal relating to corporate tax policies. Issues related to implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act.
Literal federal measure citations: H.R. 1
None.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.